Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo®
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for
Researchers sustained the organoids for nearly six years, potentially unlocking longer term studies of
Wearable sensors coupled with artificial intelligence can generate blood pressure readings nearly as well
RAHWAY, N.J. and CAMBRIDGE, MA, August 19, 2026 – Merck (NYSE: MRK), known as
Increased risk of amyotrophic lateral sclerosis (ALS) associated with herbicides, insecticides Men exposed to
Findings from clinical practice will help inform shared decision making Adding the GLP-1 receptor
With EPA’s TSCA User Fee Authority Expiring September 30, Congress Has Rare Opportunity to
China is emerging as a global biotechnology innovation hub, but its growing influence is
A panel of proteins could help match ideal candidates with preventative trials Months to
